These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34295947)

  • 61. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET.
    Ishibashi K; Saito Y; Murayama S; Kanemaru K; Oda K; Ishiwata K; Mizusawa H; Ishii K
    Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):3-11. PubMed ID: 19626324
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Skin biopsy and I-123 MIBG scintigraphy findings in idiopathic Parkinson's disease and parkinsonism: a comparative study.
    Giannoccaro MP; Donadio V; Incensi A; Pizza F; Cason E; Di Stasi V; Martinelli P; Scaglione C; Capellari S; Treglia G; Liguori R
    Mov Disord; 2015 Jun; 30(7):986-9. PubMed ID: 25778097
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
    JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson's Disease.
    Asahi T; Kashiwazaki D; Yoneyama T; Noguchi K; Kuroda S
    Neurol Med Chir (Tokyo); 2016; 56(3):125-31. PubMed ID: 26794041
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy.
    Köllensperger M; Seppi K; Liener C; Boesch S; Heute D; Mair KJ; Mueller J; Sawires M; Scherfler C; Schocke MF; Donnemilier E; Virgolini I; Wenning GK; Poewe W
    Mov Disord; 2007 Sep; 22(12):1771-6. PubMed ID: 17579357
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.
    Yoshita M; Taki J; Yokoyama K; Noguchi-Shinohara M; Matsumoto Y; Nakajima K; Yamada M
    Neurology; 2006 Jun; 66(12):1850-4. PubMed ID: 16801649
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy.
    Yoshita M
    J Neurol Sci; 1998 Feb; 155(1):60-7. PubMed ID: 9562324
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Usefulness of combining
    Niimi Y; Ito S; Murate K; Hirota S; Hikichi C; Ishikawa T; Maeda T; Nagao R; Shima S; Mizutani Y; Ueda A; Mutoh T
    J Neurol Sci; 2017 Jun; 377():174-178. PubMed ID: 28477690
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic.
    Hanyu H; Shimizu S; Hirao K; Sakurai H; Iwamoto T; Chikamori T; Hida S; Yamashina A; Koizumi K; Abe K
    Dement Geriatr Cogn Disord; 2006; 22(5-6):379-84. PubMed ID: 16960446
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [A useful marker for differential diagnosis of Parkinson's disease--MIBG myocardial scintigraphy].
    Orimo S; Amino T; Ozawa E; Kojo T; Uchihara T; Takahashi A; Tsuchiya K; Wakabayashi K; Takahashi H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):827-9. PubMed ID: 15651304
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prediction of ong-term ardiac vents by 123I-meta-odobenzylguanidine maging after acute yocardial nfarction and eperfusion herapy.
    Nakamura M; Onoguchi M; Shibutani T
    Asia Ocean J Nucl Med Biol; 2019; 7(2):121-128. PubMed ID: 31380451
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease.
    Taki J; Yoshita M; Yamada M; Tonami N
    Ann Nucl Med; 2004 Sep; 18(6):453-61. PubMed ID: 15515743
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report.
    Suzuki M; Hattori N; Orimo S; Fukumitsu N; Abo M; Kono Y; Sengoku R; Kurita A; Honda H; Inoue K
    Mov Disord; 2005 May; 20(5):634-6. PubMed ID: 15704207
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Levodopa challenge test and (123) I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson's disease.
    Asayama S; Wate R; Kaneko S; Asayama T; Oki M; Tsuge A; Nagashima M; Morita J; Nakamura S; Nakamura M; Nishii M; Fujita K; Saito A; Nakano S; Ito H; Kusaka H
    Acta Neurol Scand; 2013 Sep; 128(3):160-5. PubMed ID: 23410225
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differences in Striatal Metabolism in [
    Seiffert AP; Gómez-Grande A; Alonso-Gómez L; Méndez-Guerrero A; Villarejo-Galende A; Gómez EJ; Sánchez-González P
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611298
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease.
    Kitayama M; Wada-Isoe K; Irizawa Y; Nakashima K
    J Neurol Sci; 2008 Jan; 264(1-2):22-6. PubMed ID: 17706675
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    Yoshii F; Moriya Y; Ohnuki T; Ryo M; Takahashi W; Kohara S; Hashimoto J
    Clin Neurol Neurosurg; 2017 Sep; 160():73-77. PubMed ID: 28689103
    [TBL] [Abstract][Full Text] [Related]  

  • 79. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
    Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
    Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical relationship of myocardial sympathetic nervous activity to cardiovascular functions in chronic heart failure: assessment by myocardial scintigraphy with 123I-metaiodobenzylguanidine.
    Wada Y; Miura M; Fujiwara S; Mori S; Seiji K; Kimura T
    Tohoku J Exp Med; 2003 Dec; 201(4):261-70. PubMed ID: 14690018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.